Plain-English translation of NCT06446271 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are looking for biological markers — measurable signs in blood or urine — that can help predict who will develop cardiomyopathy (a disease of the heart muscle) and how serious it might become. Right now, doctors monitor people at risk by doing repeated heart scans and electrocardiograms, which is expensive and time-consuming. This study hopes to find a simple blood or urine test that could do the same job better and faster.
Many people inherit genetic changes that put them at risk for heart muscle disease, but doctors cannot yet tell which ones will actually get sick and which will remain healthy. A blood or urine test could help doctors identify people who need treatment early, before serious problems develop, and spare others from unnecessary repeated scans.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will donate a blood sample and urine sample, and the researchers will review your medical records and heart imaging results. You may have heart tests like electrocardiograms or echocardiograms as part of your routine care, and those results will be included in the study. The research team will follow your health over time to see which participants develop heart disease and which do not, helping them understand what the blood and urine markers can predict.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United Kingdom